What Researchers Did
Researchers reported on a 30-year-old patient with Down syndrome and stage III C Kienböck disease who was treated with 60 sessions of hyperbaric oxygen therapy.
What They Found
After 60 sessions of hyperbaric oxygen therapy, the patient showed positive clinical and radiological improvements within 6 months. These improvements included reduced pain, increased motion and strength, and nearly complete resolution of aseptic necrosis of the semilunar bone.
What This Means for Canadian Patients
This case report suggests that hyperbaric oxygen therapy could be a non-surgical treatment option for patients with advanced Kienböck disease, especially when surgery is declined. It offers a potential avenue for improving pain, movement, and bone health in individuals facing this rare and debilitating condition.
Canadian Relevance
This study has no direct Canadian connection as it was conducted outside of Canada.
Study Limitations
As a single case report, the findings cannot be generalized to a broader patient population with Kienböck disease.